In silico analysis of the oncogenic role of myoferlin (MYOF) and suggestion of folate as a potential therapeutic for brain cancer in the Caucasian population.
Journal:
Discover oncology
Published Date:
Jul 15, 2025
Abstract
BACKGROUND: Myoferlin (MYOF), a key gene in endocytosis, is known to be crucial for metastasis in cancer. While the involvement of MYOF as a biomarker is documented in cancer, a comprehensive study on its knockdown for targeted therapy via folate is a novel approach.
Authors
Keywords
No keywords available for this article.
